✦ LIBER ✦

597 Eosinophils and clinical response to the therapy with IL-2 plus INF-α in patients with kidney cancer

✍ Scribed by F. Tacconi; E. Mainardi; M. De Amici; M. Confalonieri; C. Bianchessi; E. Bobbio Pallavicini

Book ID: 116167348
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 147 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95851-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation between variegations in the

Correlation between variegations in the level of α2-globulin and the clinical response in patients with prostatic cancer following cryosurgery

✍ R.J. Ablin; M.J. Gonder; W.A. Soanes 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Relationship between estrogen receptor v

Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer

✍ David P. Byar; Mary E. Sears; William L. McGuire 📂 Article 📅 1979 🏛 Elsevier Science ⚖ 811 KB

The expression of Ki-S1 and BCL-2 and th

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

✍ J.C. Keen; J.M. Dixon; E.P. Miller; D.A. Cameron; U. Chetty; A. Hanby; C. Bellam 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 620 KB

Responses to Tamoxifen withdrawal and se

Responses to Tamoxifen withdrawal and second line endocrine therapy — Clinical clues to the mechanisms of Tamoxifen failure in patients with advanced breast cancer

✍ DeFriend, DJ; Dodwell, DJ; Anderson, H; Howell, A 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 163 KB

THE 3-MONTH CLINICAL RESPONSE TO INTRAVE

THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER

✍ SOLSONA, E.; IBORRA, I.; DUMONT, R.; RUBIO-BRIONES, J.; CASANOVA, J.; ALMENAR, S 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 61 KB

Phosphorylation of ERK1/2 mitogen-activa

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

✍ Julia M.W. Gee; John F.R. Robertson; Ian O. Ellis; Robert I. Nicholson 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 2 views